OAT6 Antibodies

Santa Cruz Biotechnology delivers a wide array of OAT6 monoclonal antibodies for advanced research in pharmacology and molecular biology. OAT6 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). OAT6, or Organic Anion Transporter 6, plays a crucial role in the transport of various endogenous and exogenous compounds across cell membranes, influencing drug disposition and metabolism. Understanding OAT6 function is essential for elucidating its involvement in pharmacokinetics and potential implications in drug interactions and toxicology. The study of OAT6 continues to reveal new insights into cellular transport mechanisms and drug development. Research focused on OAT6 has significant implications for pharmaceutical development and personalized medicine approaches. Investigating OAT6 expression patterns helps scientists better understand drug absorption and distribution across different tissues. The relationship between OAT6 and various therapeutic compounds provides valuable information for drug development strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of OAT6 and its impact on drug development and therapeutic outcomes.